Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Argus Upgrades Celgene (CELG) to Buy
-
Argus Upgrades Celgene (CELG) to Buy
-
Argus Downgrades Celgene (CELG) to Hold
-
Notable Analyst Rating Changes 11/30: (LEAP) (AGU) (NAV) Upgraded; (NFLX) (SWN) (GLW) Downgraded
-
David Moenning's Daily State of the Markets: 5/8
-
ARGUS Maintains a Hold Rating on Celgene (CELG), Sees Volatile Trading

